Bravo capsule system optimizes intragastric pH monitoring over prolonged time: Effects of ghrelin on gastric acid and hormone secretion in the rat

World Journal of Gastroenterology

Volumn 14, Issue 40, 2008, Pages 6180-6187

  Rudholm, Tobias ^a,e   Hellström, Per Mikael ^a   Theodorsson, Elvar ^b   Campbell, Colin Allan ^c   McLean, Peter Geoffrey ^c   Näslund, Erik ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c GLAXOSMITHKLINE   (United Kingdom)

^d Sweden Karolinska Institutet Department of Clinical Sciences Danderyd Hospital Stressrehab FoU Danderyd   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bravo system; Gastric acid; Ghrelin; Intragastric pH; Somatostatin

Indexed keywords

ESOMEPRAZOLE; GASTRIN; GHRELIN; PENTAGASTRIN; SOMATOSTATIN; GASTROINTESTINAL AGENT; GASTROINTESTINAL HORMONE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAVO CAPSULE SYSTEM; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG MONITORING; GASTRIC PH MONITORING; HORMONE BLOOD LEVEL; HORMONE RELEASE; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; PH MEASUREMENT; PROCESS OPTIMIZATION; REACTION TIME; STOMACH ACID SECRETION; STOMACH FISTULA; AMBULATORY MONITORING; ANIMAL; CAPSULE ENDOSCOPE; CAPSULE ENDOSCOPY; DISEASE MODEL; DRUG EFFECT; INSTRUMENTATION; METABOLISM; PATHOPHYSIOLOGY; PH; RAT; REPRODUCIBILITY; SECRETION; SPRAGUE DAWLEY RAT; STOMACH ACID; STOMACH MUCOSA; STOMACH PH; TELEMETRY; TIME; VALIDATION STUDY;

ANIMALS; CAPSULE ENDOSCOPES; CAPSULE ENDOSCOPY; DISEASE MODELS, ANIMAL; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRIC FISTULA; GASTRIC MUCOSA; GASTRINS; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HORMONES; GHRELIN; HYDROGEN-ION CONCENTRATION; MALE; MONITORING, AMBULATORY; OMEPRAZOLE; PENTAGASTRIN; PROTON PUMP INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SOMATOSTATIN; TELEMETRY; TIME FACTORS;

EID: 63449089519     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6180     Document Type: Article

References (31)

1. Shay H, Komarov SA, Gruenstein M. Effects of vagotomy in the rat. Arch Surg 1949; 59: 210-226
2. Brodie DA, Knapp PG. The mechanism of the inhibition of gastric secretion produced by esophageal ligation in the pylorus-ligated rat. Gastroenterology 1966; 50: 787-795
3. Hakanson R, Hedenbro J, Liedberg G, Sundler F, Vallgren S. Mechanisms of acid secretion after pylorus and oesophagus ligation in the rat. J Physiol 1980; 305: 139-149
4. Lane A, Ivy AC, Ivy EK. Response of the chronic gastric fistula rat to histamine. Am J Physiol 1957; 190: 221-228
5. Emas S, Nylander G, Wallin B. Comparison of the dose-response curves for acid output to pentagastrin determined by two techniques in chronic gastric fistula rats. Digestion 1981; 22: 94-100
6. Pascaud XB, Roger AR, Genton MJ. Comparison of the step-dose and single-dose acid response to histamine and pentagastrin in chronic gastric fistula rats. Digestion 1977; 16: 57-68
7. Blandizzi C, Colucci R, Carignani D, Natale G, Lazzeri G, Crema F, Del Tacca M. Role of peripheral GABAB receptors in the regulation of pepsinogen secretion in anaesthetized rats. Eur J Pharmacol 1995; 294: 191-200
8. Short GM, Wolfe MM, McGuigan JE. Pentagastrin-stimulated gastric acid secretion by the isolated perfused rat stomach. Life Sci 1984; 34: 2515-2523
9. Kleveland PM, Haugen SE, Sandvik S, Waldum HL. The effect of pentagastrin on the gastric secretion by the totally isolated vascularly perfused rat stomach. Scand J Gastroenterol 1986; 21: 379-384
10. Kleveland PM, Waldum HL, Larsson H. Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion. Scand J Gastroenterol 1987; 22: 705-713
11. Suzuki T, Yamaguchi T, Odaka T, Kobayashi M, Seza A, Kouzu T, Yokosuka O. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects. Aliment Pharmacol Ther 2008; 27: 66-71
12. Kwiatek MA, Pandolfino JE. The Bravo pH capsule system. Dig Liver Dis 2008; 40: 156-160
13. Hirano I. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease - Bilitec, intraluminal impedance and Bravo capsule pH monitoring. Aliment Pharmacol Ther 2006; 23 Suppl 1: 12-24
14. Bhat YM, McGrath KM, Bielefeldt K. Wireless esophageal pH monitoring: new technique means new questions. J Clin Gastroenterol 2006; 40: 116-121
15. Chen EP, Mahar Doan KM, Portelli S, Coatney R, Vaden V, Shi W. Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system. Pharm Res 2008; 25: 123-134
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310
17. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160
18. Schubert ML. Gastric secretion. Curr Opin Gastroenterol 2007; 23: 595-601
19. Levin F, Edholm T, Ehrstrom M, Wallin B, Schmidt PT, Kirchgessner AM, Hilsted LM, Hellstrom PM, Naslund E. Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. Regul Pept 2005; 131: 59-65
20. Kolivas S, Shulkes A. Regulation of expression of the receptors controlling gastric acidity. Regul Pept 2004; 121: 1-9
21. Lloyd KC, Raybould HE, Tache Y, Walsh JH. Role of gastrin, histamine, and acetylcholine in the gastric phase of acid secretion in anesthetized rats. Am J Physiol 1992; 262: G747-G755
22. Murakami N, Hayashida T, Kuroiwa T, Nakahara K, Ida T, Mondal MS, Nakazato M, Kojima M, Kangawa K. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J Endocrinol 2002; 174: 283-288
23. Dornonville de la Cour C, Lindstrom E, Norlen P, Hakanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004; 120: 23-32
24. Bassil AK, Haglund Y, Brown J, Rudholm T, Hellstrom PM, Naslund E, Lee K, Sanger GJ. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 2007; 150: 58-64
25. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003; 550: 227-240
26. Depoortere I, De Winter B, Thijs T, De Man J, Pelckmans P, Peeters T. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol 2005; 515: 160-168
27. Scarpignato C, Pelosini I, Di Mario F. Acid suppression therapy: where do we go from here? Dig Dis 2006; 24: 11-46
28. Hagiwara T, Mukaisho K, Ling ZQ, Sugihara H, Hattori T. Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Dig Dis Sci 2007; 52: 1219-1224
29. Schubert ML. Regulation of gastric acid secretion. Curr Opin Gastroenterol 1999; 15: 457-462
30. Hagiwara T, Mukaisho K, Ling ZQ, Sakano T, Sugihara H, Hattori T. Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats. Dig Dis Sci 2007; 52: 988-994
31. Ryberg B, Bishop AE, Bloom SR, Carlsson E, Hakanson R, Larsson H, Mattsson H, Polak JM, Sundler F. Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach. Regul Pept 1989; 25: 235-246